World's Best Scientists 2026 revealed!
Pierre-Yves Dietrich

Pierre-Yves Dietrich

D-Index & Metrics

Immunology

D-Index
72
Citations
21155
World Ranking
2199
National Ranking
57

Medicine

D-Index
73
Citations
21674
World Ranking
19615
National Ranking
298

Overview

Pierre-Yves Dietrich is affiliated with the University of Geneva in Switzerland and has contributed extensively to the field of medicine, with a primary focus on oncology. Their body of work spans multiple subfields including oncology, immunology, molecular biology, genetics, and infectious diseases.

Their research intersects a variety of topics such as:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Glioma Diagnosis and Treatment
  • Cancer survivorship and care
  • CAR-T cell therapy research
  • Colorectal and Anal Carcinomas
  • SARS-CoV-2 and COVID-19 Research

Dietrich's recent publications include:

  • "The probabilistic model of Alzheimer disease: the amyloid hypothesis revised," 2021, Nature reviews. Neuroscience
  • "Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy," 2021, Science Immunology
  • "Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma," 2020, OncoImmunology
  • "Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis," 2023, Nature Medicine
  • "Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?", 2021, Cancer Treatment Reviews

Frequent coauthors with whom Dietrich has collaborated include:

  • Valérie Dutoit
  • Solange Peters
  • Thomas McKee
  • Eliana Marinari
  • Petros Tsantoulis

Their work has been published repeatedly in venues such as:

  • Revue Médicale Suisse
  • Nature Medicine
  • Cancers
  • Journal of Clinical Oncology
  • BMC Cancer

Dietrich's extensive publication record in medicine includes 91 works, with a significant number addressing oncology through 40 publications and immunology through 13 publications. Their research contributions contribute to a broad understanding of cancer biology, immune mechanisms in cancer therapy, molecular and genetic pathways involved in disease, and infectious disease intersections.

Best Publications

  • Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

    Steffen Walter;Toni Weinschenk;Arnulf Stenzl;Romuald Zdrojowy

  • Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

    M Marchand;N van Baren;N van Baren;P Weynants;P Weynants;V Brichard;V Brichard;V Brichard

  • Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide

    Roger Stupp;Pierre Yves Dietrich;Sandrine Ostermann Kraljevic;Alessia Pica

  • Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

    Monika E. Hegi;Annie Claire Diserens;Sophie Godard;Pierre Yves Dietrich

  • Actively personalized vaccination trial for newly diagnosed glioblastoma

    Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

  • Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

    Anastasia Murat;Eugenia Migliavacca;Thierry Gorlia;Wanyu L Lambiv

  • Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

    Roger Stupp;Monika E. Hegi;Bart Neyns;Roland Goldbrunner

  • Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

    P Saas;P R Walker;M Hahne;A L Quiquerez

  • Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

    Annarita Conconi;Giovanni Martinelli;Catherine Thiéblemont;Andrés J M Ferreri

  • Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

    M. Brada;K. Hoang-Xuan;R. Rampling;P. Y. Dietrich

  • The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

    Giovanni B Frisoni;Giovanni B Frisoni;Daniele Altomare;Daniele Altomare;Dietmar Rudolf Thal;Federica Ribaldi

  • An experimentally validated panel of subfamily‐specific oligonucleotide primers (Vα1‐w29/Vβ1‐w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction

    Catherine Genevée;Anita Diu;Janine Nierat;Anne Caignard

  • MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

    Pierre Bady;Davide Sciuscio;Annie Claire Diserens;Jocelyne Bloch

  • Classification of Human Astrocytic Gliomas on the Basis of Gene Expression A Correlated Group of Genes with Angiogenic Activity Emerges As a Strong Predictor of Subtypes

    Sophie Godard;Gad Getz;Mauro Delorenzi;Pierre Farmer

  • Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98

    Giovanni Martinelli;Shu Fang Hsu Schmitz;Urs Utiger;Thomas Cerny

  • Homing Phenotypes of Tumor-Specific CD8 T Cells Are Predetermined at the Tumor Site by Crosspresenting APCs

    Thomas Calzascia;Frédérick Masson;Wilma Di Berardino-Besson;Emmanuel Contassot

  • Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy

    Valérie Dutoit;Christel Herold-Mende;Norbert Hilf;Oliver Schoor

  • Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

    Nicolas van Baren;Marie-Claude Bonnet;Brigitte Dréno;Amir Khammari

  • Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

    Laurence Albiges;Stéphane Oudard;Sylvie Negrier;Armelle Caty

  • Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.

    Alfredo Addeo;Pankil K. Shah;Natacha Bordry;Robert D. Hudson

  • Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

    Pedro Romero;Danila Valmori;Mikael J. Pittet;Alfred Zippelius

Frequent Co-Authors

Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen
Stefan Stevanovic
Stefan Stevanovic University of Tübingen
Jean-Charles Cerottini
Jean-Charles Cerottini University of Lausanne
Daniel E. Speiser
Daniel E. Speiser University of Lausanne
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Pedro Romero
Pedro Romero University of Lausanne
Solange Peters
Solange Peters University Hospital of Lausanne
Andreas von Deimling
Andreas von Deimling Heidelberg University
Danila Valmori
Danila Valmori University of Nantes
Mikael J. Pittet
Mikael J. Pittet University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing Immunology, exploring related online degrees can open diverse career opportunities in healthcare. Many students consider specialized nursing paths such as Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs, which often include hands-on experience through online pmhnp programs with clinical placement. These programs ensure graduates gain essential practical skills alongside theoretical knowledge.

Cost is a major factor when selecting a program. Prospective students may want to research the cheapest pmhnp certificate programs, which provide quality education without excessive financial burden. This accessibility helps more individuals enter the field and contribute to Immunology-related healthcare services.

Understanding potential earnings is crucial for career planning. For example, a Doctor of Nursing Practice (DNP) degree often leads to higher salaries. You can learn more about compensation by reviewing data on how much does a dnp make, helping you assess the long-term value of advanced degrees relevant to Immunology.

Additionally, for nurses already certified as Family Nurse Practitioners (FNPs), there are bridge options to specialize further. Programs like the fnp to acute care np bridge program allow smooth transitions into more acute roles, which can align with Immunology’s clinical demands.

Best Scientists Citing Pierre-Yves Dietrich

Trending Scientists